ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/N-Acetyltryptophyl-alpha-glutamylhistidyl-N-[2-oxo-4-(trifluoromethyl)-2H-1-benzopyran-7-yl]-alpha-asparagine
C38H37F3N8O11
838.7 g/mol
Research Reagent

Ac-WEHD-AFC

CAS210344-99-3
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

Ac-WEHD-AFC is a fluorogenic substrate specifically designed for caspase assays, commonly used in apoptosis research. It contains a tetrapeptide sequence (Ac-WEHD) linked to a fluorescent AFC (7-amino-4-trifluoromethylcoumarin) reporter group, which upon enzymatic cleavage releases a fluorescent signal.

fluorogenic substrate for caspase assayapoptosis research reagent

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Ac-WEHD-AFC?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ReferenceSame Category

10-Chloronaphtho[1,2-b]benzofuran

CAS2103931-83-3

research compound

ReferenceSame Category

2,2'-Binaphthyl-D14

CAS210487-05-1

research compound

ReferenceSame Category

Glu-Ala

CAS21064-18-6

research compound

ReferenceSame Category

3-(3,4-dimethoxyphenyl)propionic acid

CAS2107-70-2

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(4S)-4-[[(2S)-2-acetamido-3-(1H-indol-3-yl)propanoyl]amino]-5-[[(2S)-1-[[(2S)-3-carboxy-1-oxo-1-[[2-oxo-4-(trifluoromethyl)chromen-7-yl]amino]propan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

InChIKey

NEGOLAGPKZGIKJ-DZUOILHNSA-N

SMILES

CC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CN=CN3)C(=O)N[C@@H](CC(=O)O)C(=O)NC4=CC5=C(C=C4)C(=CC(=O)O5)C(F)(F)F

Synonyms (9)
  • Ac-WEHD-AFC

Sourcing Ac-WEHD-AFC?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→